Skin Cancer
Online ISSN : 1884-3549
Print ISSN : 0915-3535
ISSN-L : 0915-3535
Angiosarcoma of the scalp : Strategy and evaluation at the Kitasato University Hospital
Mikio MASUZAWA
Author information
JOURNAL RESTRICTED ACCESS

2009 Volume 24 Issue 3 Pages 377-384

Details
Abstract
Seventy-one patients with angiosarcoma were treated in our department during a 21-year period between 1987 and 2008. Sixty of them had angiosarcoma of the scalp, and the total number of follow-up patients was fifty-five. Of the 55 patients, 19 until 2000 were treated mainly with IL-2/LAK immunotherapy, and 36 after 2001 were treated according to our stage-distinct remedy strategy established in 2003. The basic therapeutic plan of our strategy is complete radiotherapy followed by continuous “taxoid”-chemotherapy for six months at least to prevent recurrence. As a result, our strategy indicated a better prognosis than immunotherapy only. However, lung-metastasis is still a main cause of death. Intra-pleural chemo-therapy introduced by us makes it possible to mitigate a poor prognosis.[Skin Cancer (Japan) 2009 ; 24 : 377-384]
Content from these authors
© 2009 The Japanese Skin Cancer Society
Previous article Next article
feedback
Top